Edwards Lifesciences EW
NYSE EW
$88.08 +1.25 (+1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Updated

Edwards Lifesciences' Construction in Progress came in at $301.2 million for Q4 2025, up 23.4% from $244 million a year earlier.

Analysis

Edwards Lifesciences (EW) Construction in Progress (2023 - 2025) Analysis & Trends

  • Going back by year, Construction in Progress was $244 million in FY2024 (-16.6%) and $292.5 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn -
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn -
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 911.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn -
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Agilent Technologies 49.40 Bn 42.29 Bn 1.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 301.20 Mn
Dec 31, 2024 244.00 Mn
Dec 31, 2023 292.50 Mn
API Access

Edwards Lifesciences Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=EW&period=max&api_key=YOUR_API_KEY